You can switch to Compounded Semaglutide Injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan), Oral Semaglutide ($289/mo), or explore Microdose GLP-1 Protocol ($129/mo) for a gentler approach
Emerging Fields: Researchers are now exploring their potential in non-alcoholic fatty liver disease (NAFLD), addiction (by modulating the brain's reward pathways), and even neurodegenerative diseases like Alzheimer's and Parkinson's, likely through anti-inflammatory and metabolic effects within the brain
Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1 Portfolio Shanghai May 17, 2024 Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui), one of the largest pharmaceutical companies in China, on its licensing of global rights (excluding Greater China) for the development, production and commercialization of three of its proprietary glucagon-like peptide-1 (GLP-1) drugs to Hercules CM Newco (Hercules), a newly established Delaware company
Managing side effects that contribute to UTI risk Since the primary pathway from semaglutide to UTIs runs through GI side effects and dehydration, managing those side effects effectively is itself a UTI prevention strategy
